1. Home
  2. /
  3. Available
  4. /
  5. The cost and cost-effectiveness of novel tuberculosis vaccines in low- and middle-income countries: A modeling study

The cost and cost-effectiveness of novel tuberculosis vaccines in low- and middle-income countries: A modeling study

Description

We assessed future costs, cost-savings, and cost-effectiveness of introducing novel TB vaccines in low- and middle-income countries (LMICs) for a range of product characteristics and delivery strategies.
WHO goals and milestones

Resources

Contact

Joeri Buis

KNCV Team

Contact me for more information about this research

Click to copy link of this header Menu

Add A Knowledge Base Question !

You will receive an email when your question will be answered.

+ = Verify Human or Spambot ?